Plain-English translation of NCT07444008 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study is testing a dietary supplement called BioAmicus Complete, which is a mixture of 10 beneficial bacteria strains given as oral drops. The trial will look at whether this medication can reduce symptoms like infant colic, constipation, diarrhea, and allergic skin rashes (eczema) in babies during their first few months of life. Half of the babies will receive the active drops, and half will receive a placebo (inactive drops) to see if the treatment truly works.
Many babies experience uncomfortable digestive problems and allergic skin reactions in their early weeks of life, and parents are looking for safe, gentle treatments. This trial is investigating whether this medication, which contains helpful bacteria, might naturally ease these symptoms without stronger medications.
You likely qualify if…
You likely don't qualify if…
If you enroll, you will give your baby the drops or placebo once a day for 25 days. You will keep a daily diary recording your baby's symptoms like colic, bowel habits, and skin condition. You can also give your baby other common over-the-counter treatments (like simethicone drops for gas) if needed. The study team will check in with you regularly to see how your baby is doing.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
Russia